Obermatt
See Similar Stocks →

Flags

Earnings warning

Hanmi Science

KSC:008930 · KR7008930000
Health Care Providers & ServicesSmall

360

57
Medium confidence — indicative
Profit price41
Owner Earnings Yield76
Dividend Yield1
Price/Sales40
EV / Gross Profit32
Price/Book26
Return on Capital34
Cash Return on Capital84
Return on Equity82
EBIT Margin39
Gross Profitability47
Cash Conversion1
Accruals25
Owner Earnings Margin78
Sales growth52
Profit Growth69
Long-Term EPS Growth22
Owner Earnings Growth85
Reinvestment70
Price momentum36
Debt load64
Refinancing12
Debt Payback66
Liquidity45
Analyst ratings—
Expectations trend—
Market mood75
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Hanmi Science generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountrySouth Korea
IndustryHealth Care Providers & Services
SizeSmall
TypePublic Company
ExchangeKOSE
Employees33
Websitehanmiscience.co.kr
ISINKR7008930000
Last UpdateApr 2, 2026
Indices
KOSPI (South Korea)
Themes
DiabetesNutraceuticalOncology

Description

Analysis

Middle-of-the-road

Hanmi Science Co., Ltd. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is attractive. The owner-earnings multiple stands at 14.9×; owner earnings: the cash an owner could take out each year.

Growth is tepid; the safety picture is sturdy. The company scores 14/20 on our value-creation score: strong value creator. Analysts lean positive.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
34
20232026

All-time high

52

Mar 2026

All-time low

25

Jan 2023

Average rank

37

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
40
—
—
46
Price/Earnings
44
—
—
16
Price/Book
26
—
—
20
Dividend Yield
1
—
—
21
Value (overall)
19
—
—
19

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Hanmi Science with its peers
Il Dong Pharmaceutical
KSC:249420
53
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Bora Pharmaceuticals
TAI:6472
27
CountryTaiwan
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Towa Pharmaceutical
TYO:4553
50
CountryJapan
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
Kolmar Korea
KSC:161890
53
CountrySouth Korea
IndustryPersonal Products
SizeMedium
Full Stock Analysis →
H.U. Group Holdings
TYO:4544
83
CountryJapan
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Yakult Honsha
TYO:2267
17
CountryJapan
IndustryFood Products
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →